IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 174 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $251,000 | -7.4% | 9,144 | -0.2% | 0.05% | -18.6% |
| Q1 2020 | $271,000 | +7.5% | 9,164 | +0.5% | 0.06% | +18.0% |
| Q4 2019 | $252,000 | +64.7% | 9,114 | +8.3% | 0.05% | +42.9% |
| Q3 2019 | $153,000 | -26.1% | 8,414 | 0.0% | 0.04% | -23.9% |
| Q2 2019 | $207,000 | +209.0% | 8,414 | +20.2% | 0.05% | +170.6% |
| Q1 2019 | $67,000 | +15.5% | 7,000 | +7.7% | 0.02% | +6.2% |
| Q4 2018 | $58,000 | -22.7% | 6,500 | -3.0% | 0.02% | -11.1% |
| Q3 2018 | $75,000 | -30.6% | 6,700 | -20.7% | 0.02% | -33.3% |
| Q2 2018 | $108,000 | -34.9% | 8,450 | -14.0% | 0.03% | -38.6% |
| Q1 2018 | $166,000 | +14.5% | 9,825 | -46.3% | 0.04% | +7.3% |
| Q4 2017 | $145,000 | -3.3% | 18,313 | -5.2% | 0.04% | -8.9% |
| Q3 2017 | $150,000 | – | 19,313 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |